Perceptive Advisors LLC View Ray, Inc. Transaction History

Perceptive Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.94 - $6.75 $2.96 Million - $5.07 Million	-751,748 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.03 - $7.25 $6.85 Million - $12.3 Million	-1,700,000 Reduced 69.34%	751,748 $3.27 Million
Q3 2019 Nov 14, 2019	SELL	$2.9 - $9.56 $8.71 Million - $28.7 Million	-3,003,495 Reduced 55.06%	2,451,748 $7.11 Million
Q2 2019 Aug 14, 2019	BUY	$6.7 - $9.13 $4.35 Million - $5.93 Million	649,593 Added 13.52%	5,455,243 $48.1 Million
Q1 2019 May 15, 2019	BUY	$5.7 - $8.73 $5.13 Million - $7.86 Million	900,000 Added 23.04%	4,805,650 $35.5 Million
Q4 2018 Feb 14, 2019	BUY	$5.04 - $10.28 $1.04 Million - $2.11 Million	205,650 Added 5.56%	3,905,650 $21.7 Million
Q3 2018 Nov 14, 2018	BUY	$7.12 - $12.44 $25.8 Million - $45.1 Million	3,625,000 Added 4833.33%	3,700,000 $34.6 Million
Q2 2018 Aug 14, 2018	SELL	$6.21 - $8.21 $155,250 - $205,250	-25,000 Reduced 25.0%	75,000 $519,000
Q1 2018 May 15, 2018	BUY	$6.26 - $10.12 $313,000 - $505,999	50,000 Added 100.0%	100,000 $643,000
Q4 2017 Feb 14, 2018	BUY	$5.6 - $9.9 $280,000 - $495,000	50,000	50,000 $463,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.